Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is 20 439,11 Kč, with a 24-hour trading volume of 28,25B Kč. The asset's market cap is 18,25T Kč, after moving -3.32% in the last day.
Tokenized Eli Lilly And Co is trading at 20 481,44 Kč, with a tokenized market cap of 112,48M Kč and a 24-hour trading volume of 60,77M Kč. The tokenized asset has moved -2.70% in the past 24 hours.